Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Pertussis toxin may contribute to hair loss in alopecia areata.

Angelica sinensis helps repair and regenerate the thymus in mice.

Blocking LFA-1 prevents hair loss in mice.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

New therapies are being developed that target integrin pathways to treat various diseases.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Cyclosporine effectively treated a woman's stubborn skin condition.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Ebastine may help regrow hair in alopecia areata patients.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Entospletinib effectively prevents eye and skin GVHD in mice.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Itraconazole may cause low platelet and white blood cell counts.